Skip to content

R&D at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$336M-1.8%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$65.79M+11.4%
Zoetis logo
ZoetisZTS
$180M+11.1%
Revvity logo
RevvityRVTY
$57.89M+8.0%
Merck & Co. logo
Merck & Co.MRK
$12.59B+248%
TEC
Bio-TechneTECH
$23.46M-4.6%

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$1.96B+95.6%
Enterprise value$2.59B+46.1%
P/S2.3×+1.1×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Reported directly by Neogen in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Neogen’s 10-Q, filed April 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neogen's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neogen's R&D?
Neogen (NEOG) reported R&D of $3.8M in Q4 2025.
How has Neogen's R&D changed year-over-year?
Neogen's R&D decreased by 15.6% year-over-year, from $4.5M to $3.8M.
What is the long-term trend for Neogen's R&D?
Over 3 years (2022 to 2025), Neogen's R&D has grown at a 7.4% compound annual growth rate (CAGR), from $17.05M to $21.09M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.